Skip to content

An evidence-based study on acupuncture anesthesia using colonoscopy as a carrier

An evidence-based study on acupuncture anesthesia using colonoscopy as a carrier

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001361
Enrollment
Unknown
Registered
2025-07-09
Start date
2025-01-01
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acupuncture anesthesia under colonoscopy

Interventions

sham acupuncture group:sham acupuncture
acupuncture group:acupuncture

Sponsors

Department of Anesthesiology General Hospital of Tianjin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age = 18 and = 65 years old with no restriction on gender; Patients receiving painless colonoscopy diagnosis and treatment; ASA (American Society of Anesthesiologists) physical status classification of I or II; BMI (Body Mass Index) > 18 kg/m² and < 28 kg/m²

Exclusion criteria

Exclusion criteria: Patients planned for endotracheal intubation (including laryngeal mask); Patients requiring complex endoscopic diagnostic and therapeutic procedures; Patients with a history of intestinal stenosis or adhesion; Patients with acute heart failure; unstable angina pectoris; myocardial infarction within 6 months prior to screening; Patients with severe respiratory lesions; Patients with psychiatric disorders a history of long-term use of psychiatric medications and cognitive dysfunction; Patients judged to have difficult airway management (Modified Mallampati Score of Grade IV); Patients with severely impaired functions of vital organs such as the liver and kidneys; Patients with a history of drug abuse drug addiction or alcoholism within 2 years prior to the screening period where alcoholism is defined as an average daily consumption of more than 2 units of alcohol (1 unit = 360 mL of beer or 45 mL of spirits with 40% alcohol content or 150 mL of wine); Patients who have not received regular antihypertensive treatment or have poorly controlled blood pressure (sitting systolic blood pressure =160 mmHg or =90 mmHg and/or sitting diastolic blood pressure =100 mmHg during the screening period); Patients taking benzodiazepines and/or opioids daily for a month or intermittently within the past three months; Patients allergic to or having contraindications for opioids propofol and other related drug components; Pregnant or lactating women; Patients (including males) planning to conceive within 3 months; Patients who have participated as subjects in any clinical trial within the past 3 months; Patients deemed unsuitable for participation in this trial by the investigator

Design outcomes

Primary

MeasureTime frame
The dosage of propofol per kilogram of body weight per minute;

Secondary

MeasureTime frame
Dosage of propofol per kilogram of body weight;Evaluation of sedation quality;The total dosage of propofol and the administration of additional doses;Evaluation of Colonoscopy Quality;Evaluation of anesthesia safety;Evaluation of patient and physician satisfaction;

Countries

China

Contacts

Public ContactChunyan Wang

Department of Anesthesiology General Hospital of Tianjin Medical University

0208wcy@163.com13512206486

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026